Cargando…

Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system

Detalles Bibliográficos
Autores principales:	Rivera-Caravaca, José Miguel, Lip, Gregory Y. H., Roldán, Vanessa, Marín, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619039/ https://www.ncbi.nlm.nih.gov/pubmed/36324744 http://dx.doi.org/10.3389/fcvm.2022.1042728

Ejemplares similares

Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2019)

Non-vitamin K Antagonist Oral Anticoagulants and Drug-Food Interactions: Implications for Clinical Practice and Potential Role of Probiotics and Prebiotics
por: Sánchez-Fuentes, Ana, et al.
Publicado: (2022)

The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2022)

Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry
por: Esteve-Pastor, María Asunción, et al.
Publicado: (2022)

Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial
por: Ding, Wern Yew, et al.
Publicado: (2022)

Relation of the ‘Atrial Fibrillation Better Care (ABC) Pathway’ to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists
por: Roldán, Vanessa, et al.
Publicado: (2022)

Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS
por: Ding, Wern Yew, et al.
Publicado: (2021)

Editorial: Atrial fibrillation in dementia
por: Gotzmann, Michael, et al.
Publicado: (2023)

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2017)

Editorial: Mechanism and prevention of atrial fibrillation
por: Li, Guowei, et al.
Publicado: (2022)

Long‐Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC‐Stroke and CHA (2) DS (2)‐VASc Scores
por: Rivera‐Caravaca, José Miguel, et al.
Publicado: (2017)

Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?
por: García-Fernández, Amaya, et al.
Publicado: (2017)

Integrated Care of Atrial Fibrillation Using the ABC (Atrial fibrillation Better Care) Pathway Improves Clinical Outcomes in Chinese Population: An Analysis From the Chinese Atrial Fibrillation Registry
por: Wang, Yu-Feng, et al.
Publicado: (2021)

Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and stroke
por: Qureshi, Ahmed, et al.
Publicado: (2023)

Editorial: MicroRNAs—clinical biomarkers for atrial fibrillation
por: Moscoso, Isabel, et al.
Publicado: (2023)

Electronic health record-wide association study for atrial fibrillation in a British cohort
por: Chung, Sheng-Chia, et al.
Publicado: (2023)

Type and Severity of Migraine Determines Risk of Atrial Fibrillation in Women
por: Rhee, Tae-Min, et al.
Publicado: (2022)

Seasonality, incidence and prognosis in atrial fibrillation and stroke in Denmark and New Zealand
por: Christensen, Anette Luther, et al.
Publicado: (2012)

At the heart of the matter: how mental stress and negative emotions affect atrial fibrillation
por: Leo, Donato Giuseppe, et al.
Publicado: (2023)

Editorial: The role of genetics and non-coding RNAs in atrial fibrillation
por: Novelli, Valeria, et al.
Publicado: (2022)

Editorial: Atrial fibrillation: insights on mechanisms, mapping and catheter ablation
por: Conti, Sergio, et al.
Publicado: (2023)

Clustering of Unhealthy Lifestyle and the Risk of Adverse Events in Patients With Atrial Fibrillation
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Editorial: Innovative Approaches to Tackle Atrial Fibrillation: From Bench to Bedside
por: Ai, Xun, et al.
Publicado: (2020)

Editorial: Effects of oral anticoagulant therapy in atrial fibrillation patients with comorbidities
por: Li, Runkai, et al.
Publicado: (2023)

Editorial: Pathophysiological and clinical insights for atrial fibrillation/flutter or heart failure
por: Lin, Chun, et al.
Publicado: (2023)

The “obesity paradox” in patients with atrial fibrillation: Insights from the Gulf SAFE registry
por: Li, Yan-Guang, et al.
Publicado: (2022)

Editorial: Evaluation of the left atrium: Its role in atrial fibrillation and diastolic function
por: Thomas, Liza, et al.
Publicado: (2023)

Editorial: Novel strategies for persistent atrial fibrillation ablation and AF driver mapping
por: Qin, Mu, et al.
Publicado: (2023)

Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2022)

Efficacy and Safety of Oral Anticoagulants for Atrial Fibrillation Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Rhee, Tae-Min, et al.
Publicado: (2022)

A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial
por: Kotecha, Dipak, et al.
Publicado: (2017)

Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients
por: Lin, Yu-Sheng, et al.
Publicado: (2021)

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study
por: Sørensen, Rikke, et al.
Publicado: (2013)

Modified Taiwan Atrial Fibrillation Score for the Prediction of Incident Atrial Fibrillation
por: Liao, Jo-Nan, et al.
Publicado: (2022)

The Atrium in Atrial Fibrillation – A Clinical Review on How to Manage Atrial Fibrotic Substrates
por: Cunha, Pedro Silva, et al.
Publicado: (2022)

Associations between obesity parameters and the risk of incident atrial fibrillation and ischaemic stroke in the different age groups
por: Ahn, Hyo-Jeong, et al.
Publicado: (2022)

Atrial Fibrillation and Cancer
por: Hajjar, Ludhmila Abrahao, et al.
Publicado: (2021)

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Renal outcomes of rivaroxaban compared with warfarin in Asian patients with nonvalvular atrial fibrillation: A nationwide population-based cohort study
por: Lee, So-Ryoung, et al.
Publicado: (2023)

Left atrial appendage exclusion in atrial fibrillation
por: Rozen, Guy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j5olmthels48512bplgopsrcv3